Beth A. Martin

Also affiliated with Palo Alto University, Stanford University

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?”.

Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?

Immunotherapy Advances(2022)10.1093/immadv/ltac012

N/A

0DataRank · unranked

51 citations

Kalin L. Wilson, Vinay K. Giri, Han Zhu, Shuchi Anand, Kavitha Ramchandran +4 more

An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and Genomiser

Genome Medicine(2025)10.1186/s13073-025-01546-1

N/A

0DataRank · unranked

8 citations

Shruti Marwaha, Alistair Ward, Shilpa N. Kobren, Jennefer N. Carter, Undiagnosed Diseases Network +94 more